Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Philadelphia, Pennsylvania 19141


Patients presenting to the ED with a chief complaint of acute low back pain and whom the providing physician feels symptomatic treatment is appropriate in the ED will be screened for inclusion in the study. The purpose of the study is to compare Transcutaneous Electrical Nerve Stimulation (TENS) as an adjunct to ibuprofen in the treatment of acute low back pain in the emergency department. Therefore, the aim of this prospective, randomized, double blind study is to evaluate the efficacy of ED administered TENS in acute low back pain patients during their ED visit.

Study summary:

The study is a double blind, randomized, placebo controlled trial. One group will receive ibuprofen and TENS. The comparison group will receive ibuprofen and sham TENS. The study primary endpoint is change in pain level on Visual Analog Scale score at 45-60 minutes after TENS start. This is a two-arm, double blind, randomized control trial evaluating the patient perceived improvement in back pain. Patients will first fill out a Visual Analog Scale (VAS). Patients will be randomized to one of two arms. Ibuprofen 800 mg, plus sham TENS for 45 minutes Ibuprofen 800 mg, plus TENS for 45 minutes Patients will be given a 2nd VAS scale up to 15 minutes after the end of the TENS session. After the second VAS the patients will be finished with the study procedures and can be continued to be cared as per the discretion of their treating physician. Our intention is to detect a 20% reduction in pain by VAS with a common standard deviation equal to the difference at the p = 0.05 level with a power of 80% using an analysis of variance (ANOVA). The calculated sample size required 28 patients per group. Considering the uncertain dropout rate, the investigators decided to enroll at least 66 patients. Baseline characteristics will be calculated to determine if groups are equal. A two-way repeated-measures ANOVA will be used to test both a trial effect and a group effect (SPSS 20, SPSS Inc., Chicago, IL). Data will be presented as means with standard deviations with 95% confidence intervals. A p< 0.05 was considered statistically significant.


Inclusion Criteria: 1. Patients 18 years to 65 years of age presenting to the emergency room with a primary complaint of low back pain. 2. Patient is receiving 800mg dose of ibuprofen as part of their treatment regimen for back pain 3. Back pain new in the last 48 hours 4. Deemed by the treating physician to have musculoskeletal back pain, and no central/peripheral nervous system pathology as the cause of their pain. Exclusion Criteria: 1. Allergy to ibuprofen. 2. Hypotension (MAP <65 or Systolic BP <100), fever, tachycardia 3. Paresthesias, isolated motor weakness, or objective sensory deficit on physical exam 4. Radicular symptoms 5. Urinary incontinence or retention 6. Bowel incontinence 7. Unexplained weight loss of >15 lbs in the last 3 months. 8. Multiple primary complaints in the ED. 9. Received Analgesia other than Ibuprofen as part of their ED work up. 10. Taken prescription strength pain medication within the last 12 hours for any condition. 11. History of active malignancy, HIV, organ transplantation, active hemodialysis 12. Currently pregnant 13. Nursing home residents 14. Currently in police custody



Primary Contact:

Principal Investigator
Paul G Dominici, MD
Albert Einstein Healthcare Network

Backup Contact:


Location Contact:

Philadelphia, Pennsylvania 19141
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.